| Authors: |
Gauvin DV; Department of Neurobehavioral Sciences, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA. Electronic address: david.gauvin@mpiresearch.com., Yoder JD; Department of Neurobehavioral Sciences, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA., Holdsworth DL; Department of Safety Pharmacology, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA., Harter ML; Department of Safety Pharmacology, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA., May JR; Department of Safety Pharmacology, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA., Cotey N; Department of Safety Pharmacology, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA., Dalton JA; Department of Safety Pharmacology, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA., Baird TJ; Department of Drug Safety Evaluation, MPI Research, 54943 North Main Street, Mattawan, MI 49071, USA. |
